Hualan Biological Engineering Inc. (SHE:002007)
15.04
-0.03 (-0.20%)
Apr 17, 2026, 3:04 PM CST
SHE:002007 Market Cap
SHE:002007 has a market cap or net worth of 27.48 billion as of April 17, 2026. Its market cap has decreased by -6.65% in one year.
Market Cap
27.48B
Enterprise Value
25.43B
Revenue
4.60B
Ranking
n/a
PE Ratio
29.20
Stock Price
15.04
Market Cap Chart
Since March 3, 2005, SHE:002007's market cap has increased from 1.18B to 27.48B, an increase of 2,226.86%. That is a compound annual growth rate of 16.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 27.48B | -0.59% |
| Dec 31, 2025 | 27.65B | -10.27% |
| Dec 31, 2024 | 30.81B | -23.86% |
| Dec 29, 2023 | 40.47B | -1.97% |
| Dec 30, 2022 | 41.29B | -22.34% |
| Dec 31, 2021 | 53.16B | -31.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shanghai Allist Pharmaceuticals | 43.91B |
| Asymchem Laboratories (Tianjin) | 40.36B |
| Hebei Changshan Biochemical Pharmaceutical | 40.14B |
| Shanghai RAAS Blood Products | 37.37B |
| Chongqing Zhifei Biological Products | 37.03B |
| Beijing Tiantan Biological Products | 30.02B |
| Xiamen Amoytop Biotech | 26.37B |
| Suzhou Zelgen Biopharmaceuticals | 26.15B |